Popular diabetes drugs such as Ozempic and Trulicity are among 25 drugs Medicare has spent the most on but hasn't yet selected for price negotiation, according to a report released Thursday.

Trulicity is still the market leader with sales of $4.13 billion last year, a rise of 29%, but Ozempic has been gaining ground. Novo Nordisk’s drug grew 142% in 2019 to $1.6 billion. While ...

When researchers in Italy analyzed thousands of Reddit threads about GLP-1 agonists, the drug class that includes Ozempic and Wegovy, (Victoza and Saxenda (liraglutide), Trulicity (dulaglutide ...

Popular diabetes drugs such as Ozempic and Trulicity are among 25 drugs Medicare has spent the most on but hasn't yet ...